The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

If you’re older, you may get a more severe infection than a younger person would, especially if you have an underlying chronic condition.” While vaccines don’t prevent older adults from getting ...

COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...

The new five-type index, developed by federal researchers with the National Institutes of Health’s RECOVER COVID Initiative, ...

With the Trump administration announcing plans to impose 25% tariffs on pharmaceuticals, it reignites a critical discussion ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Seasonal influenza has reached its highest levels in over 15 years and has now surpassed COVID-19 deaths for the past two ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

We recently compiled a list of the 12 Best Get Rich Fast Stocks To Buy Now. In this article, we are going to take a look at ...

After a promising decline on the 6th week of 2025, the number of people seeking medical help with respiratory infection, ...

International researchers, including from DTU National Food Institute, warn that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more ...